Smith Group Asset Management’s Emergent Biosolutions EBS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-50	Closed	-$3K	–	376
2021 Q2	$3K	Hold	50	–	–	﹤0.01%	352
2021 Q1	$5K	Sell	50 -1,390	-97%	-$142K	﹤0.01%	307
2020 Q4	$129K	Sell	1,440 -10	-0.7%	-$918	0.01%	199
2020 Q3	$150K	Sell	1,450 -310	-18%	-$33.4K	0.01%	183
2020 Q2	$139K	Sell	1,760 -30	-2%	-$2.24K	0.01%	182
2020 Q1	$104K	Hold	1,790	–	–	0.01%	212
2019 Q4	$97K	Hold	1,790	–	–	﹤0.01%	240
2019 Q3	$94K	Buy	1,790 +320	+22%	+$14.9K	﹤0.01%	243
2019 Q2	$71K	Sell	1,470 -220	-13%	-$10.5K	﹤0.01%	256
2019 Q1	$85K	Sell	1,690 -4,584	-73%	-$270K	﹤0.01%	269
2018 Q4	$372K	Sell	6,274 -103	-2%	-$6.64K	0.01%	205
2018 Q3	$420K	Buy	6,377 +5,970	+1,467%	+$348K	0.01%	204
2018 Q2	$21K	Buy	407 +25	+7%	+$1.3K	﹤0.01%	384
2018 Q1	$20K	Hold	382	–	–	﹤0.01%	395
2017 Q4	$18K	Hold	382	–	–	﹤0.01%	405
2017 Q3	$15K	Hold	382	–	–	﹤0.01%	414
2017 Q2	$13K	Hold	382	–	–	﹤0.01%	419
2017 Q1	$11K	Hold	382	–	–	﹤0.01%	404
2016 Q4	$13K	Hold	382	–	–	﹤0.01%	404
2016 Q3	$12K	Sell	382 -7,010	-95%	-$204K	﹤0.01%	406
2016 Q2	$208K	Buy	7,392 +7,010	+1,835%	+$275K	0.01%	249
2016 Q1	$14K	Sell	382 -20	-5%	-$706	﹤0.01%	383
2015 Q4	$16K	Sell	402 -3	-0.7%	-$105	﹤0.01%	404
2015 Q3	$12K	Hold	405	–	–	﹤0.01%	349
2015 Q2	$13K	Sell	405 -3	-0.7%	-$93	﹤0.01%	337
2015 Q1	$12K	Buy	408 +180	+79%	+$5.16K	﹤0.01%	377
2014 Q4	$6K	Hold	228	–	–	﹤0.01%	387
2014 Q3	$5K	Sell	228 -350	-61%	-$8.01K	﹤0.01%	358
2014 Q2	$13K	Sell	578 -52,036	-99%	-$1.21M	﹤0.01%	323
2014 Q1	$1.33M	Buy	+52,614	New	+$1.33M	0.05%	174